Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: Results from the SWEFOT trial

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Rezaei, Hamed ^a,b   Saevarsdottir, Saedis ^b   Geborek, Pierre ^c   Petersson, Ingemar F ^d   Van Vollenhoven, Ronald F ^a,b   Forslind, Kristina ^c,d,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; BONE DENSITY; DIGITAL X RAY RADIOGRAMMETRY; DRUG DOSE ESCALATION; FEMALE; HAND BONE; HAND BONE LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OSTEOLYSIS; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHARP VAN DER HEIJDE SCORE;

ABSORPTIOMETRY, PHOTON; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; FEMALE; HAND BONES; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SULFASALAZINE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874460583     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-79     Document Type: Article

References (29)

1. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. van der Heijde DM, Baillieres Clin Rheumatol 1996 10 3 435 453 10.1016/S0950-3579(96)80043-4 8876953
2. Better guidelines to rheumatoid arthritis therapy. Edmonds J, Lassere M, Aust N Z J Med 1993 23 2 143 145 10.1111/j.1445-5994.1993.tb01806.x 8517836
3. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis. van der Heijde DM, Rheumatology (Oxford) 2000 39 Suppl 1 9 16 10.1093/oxfordjournals.rheumatology.a031496 (Pubitemid 30352938)
4. Use of the radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold. Brower AC, Arthritis Rheum 1990 33 3 316 324 10.1002/art.1780330303 2180404 (Pubitemid 20109182)
5. Digital radiogrammetry as a new diagnostic tool for estimation of disease-related osteoporosis in rheumatoid arthritis compared with pQCT. Bottcher J, Pfeil A, Heinrich B, Lehmann G, Petrovitch A, Hansch A, Heyne JP, Mentzel HJ, Malich A, Hein G, Rheumatol Int 2005 25 6 457 464 10.1007/s00296-004-0560-z 15761729 (Pubitemid 41186916)
6. Does active treatment of rheumatoid arthritis limit disease-associated bone loss? Dolan AL, Moniz C, Abraha H, Pitt P, Rheumatology (Oxford) 2002 41 9 1047 1051 10.1093/rheumatology/41.9.1047
7. Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Jensen T, Klarlund M, Hansen M, Jensen KE, Podenphant J, Hansen TM, Skjodt H, Hyldstrup L, Ann Rheum Dis 2004 63 1 15 22 10.1136/ard.2003.013888 14672886 (Pubitemid 38064598)
8. Interobserver variation in the detection of osteopenia by radiography and comparison with dual X-ray absorptiometry of the lumbar spine. Jergas M, Uffmann M, Escher H, Gluer CC, Young KC, Grampp S, Koster O, Genant HK, Skeletal Radiol 1994 23 3 195 199 8016671 (Pubitemid 24106708)
9. Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis. Forslind K, Boonen A, Albertsson K, Hafstrom I, Svensson B, Scand J Rheumatol 2009 38 6 431 438 10.3109/03009740902939376 19922017
10. Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. Hoff M, Haugeberg G, Kvien TK, Arthritis Res Ther 2007 9 4 81 10.1186/ar2280 17705865 (Pubitemid 47382492)
11. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Hoff M, Haugeberg G, Odegard S, Syversen S, Landewe R, van der Heijde D, Kvien TK, Ann Rheum Dis 2009 68 3 324 329 10.1136/ard.2007.085985 18339664
12. Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis. Kapetanovic MC, Lindqvist E, Algulin J, Jonsson K, Saxne T, Eberhardt K, Geborek P, Arthritis Res Ther 2011 13 1 31 10.1186/ar3259 21345204
13. Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis? Forslind K, Kalvesten J, Hafstrom I, Svensson B, Study Group B, Arthritis Res Ther 2012 14 5 219 Epub ahead of print 10.1186/ar4058 23068060
14. The radiological diagnosis of osteoporosis: a new approach. Barnett E, Nordin BE, Clin Radiol 1960 11 166 174 10.1016/S0009-9260(60)80012-8 14408427
15. Potential clinical relevance of digital radiogrammetry for quantification of periarticular bone demineralization in patients suffering from rheumatoid arthritis depending on severity and compared with DXA. Bottcher J, Malich A, Pfeil A, Petrovitch A, Lehmann G, Heyne JP, Hein G, Kaiser WA, Eur Radiol 2004 14 4 631 637 10.1007/s00330-003-2087-1 14600776 (Pubitemid 38444576)
16. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Coster L, Waltbrand E, Zickert A, Theander J, Thorner A, Hellstrom H, Lancet 2009 374 9688 459 466 10.1016/S0140-6736(09) 60944-2 19665644
17. How to read radiographs according to the Sharp/van der Heijde method. van der Heijde D, J Rheumatol 1999 26 3 743 745 10090194 (Pubitemid 29125603)
18. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial. Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF, Ann Rheum Dis 2012 71 2 186 191 10.1136/annrheumdis-2011-200038 21930734
19. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL, Arthritis Rheum 1995 38 1 44 48 10.1002/art.1780380107 7818570
20. Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL, Ann Rheum Dis 2009 68 6 954 960 10.1136/ard.2007.084459 18490431
21. Assessing disability in patients with rheumatoid arthritis. Use of a swedish version of the stanford health assessment questionnaire. Ekdahl C, Eberhardt K, Andersson SI, Svensson B, Scand J Rheumatol 1988 17 4 263 271 10.3109/03009748809098795 3187457
22. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van't Hof MA, van Rijswijk MH, van de Putte LB, Arthritis Rheum 1992 35 1 26 34 10.1002/art.1780350105 1731813
23. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D, Ann Rheum Dis 2005 64 2 179 182 10.1136/ard.2003.018457 15286006 (Pubitemid 40193607)
24. Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis. Guler-Yuksel M, Klarenbeek NB, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van der Kooij SM, Gerards AH, Ronday HK, Huizinga TW, Dijkmans BA, Allaart CF, Arthritis Res Ther 2010 12 3 96 10.1186/ar3025 20482894
25. Estimation of bone mineral density by digital X-ray radiogrammetry: theoretical background and clinical testing. Rosholm A, Hyldstrup L, Backsgaard L, Grunkin M, Thodberg HH, Osteoporos Int 2001 12 11 961 969 10.1007/s001980170026 11804024 (Pubitemid 34001011)
26. Loss of metacarpal bone density predicts RA development in recent-onset arthritis. de Rooy DP, Kalvesten J, Huizinga TW, van der Helm-van Mil AH, Rheumatology (Oxford) 2012 51 6 1037 1041 10.1093/rheumatology/ker435
27. Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study. Stewart A, Mackenzie LM, Black AJ, Reid DM, Rheumatology (Oxford) 2004 43 12 1561 1564 10.1093/rheumatology/keh385 (Pubitemid 39642583)
28. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Hoff M, Kvien TK, Kalvesten J, Elden A, Haugeberg G, Ann Rheum Dis 2009 68 7 1171 1176 10.1136/ard.2008.091264 18801760
29. EULAR recommendations for the management of early arthritis: report of a task force of the European standing committee for international clinical studies including therapeutics (ESCISIT). Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Ann Rheum Dis 2007 66 1 34 45 16396980 (Pubitemid 46044858)